about
Prevention of cerebral embolism progression by emergency surgery of the left atrial myxomaPrevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.Diagnosis of a subarachnoid hemorrhage with only mild symptoms using computed tomography in Japan.Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.Preoperative high-dose steroid has long-term beneficial effects for myasthenia gravis.Importance of Distinguishing Between Mitochondrial Encephalomyopathy With Elderly Onset of Stroke-Like Episodes and Cerebral Infarction.Difficulty in determining the association of a single nucleotide polymorphism in the ZNF512B gene with the risk and prognosis of amyotrophic lateral sclerosis.Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis.Utility of cystatin C for renal function in amyotrophic lateral sclerosis.[Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].Central nervous system tuberculoma with miliary tuberculosis in the elderlyReversible lesion in the splenium of the corpus callosumAn Autopsy Case of Varicella Zoster Virus Encephalitis with Multiple Brain LesionsPosterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristicsSlightly Symptomatic Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Remission in Four MonthsReversible lesion in the splenium of the corpus callosum in a patient with chronic alcoholism
P50
Q35543748-3140C9C9-96B9-458F-8A6C-EA9D615C16E6Q36071538-E1FFF17F-6C2F-488E-B35C-95A98FEAB1B7Q36166632-DF49A4D9-19AB-40A6-9CC9-F469B2975620Q36381783-3CE5CF1C-4143-4A17-AAA4-45DAE693F50AQ37057779-ABA3978C-1852-4377-A9FA-331FF8905328Q38641960-769DC09E-3A77-42D7-A978-333633FD1CA7Q39455536-D485B039-5B8F-4196-AF47-D4C342A6CC4FQ40574919-2A313D73-1189-4D39-AAB9-812580B16A63Q43784480-386D231A-6686-4ACE-A703-A8E6FE661E13Q44228898-79C191D9-B92E-4B81-94AE-3A954B4BB6B5Q45167008-81BCE605-BE92-4A87-ACB1-74114355583BQ46417805-E62E1A88-76CF-4A7D-BE76-F97FED981FEAQ89703750-E14542E5-C15E-4623-AEEC-E4FE9408FA1BQ90544086-C4B83A69-E88C-49BE-BD40-F33037A9B8DEQ90835030-4E147F66-005E-4C31-A811-B19FCDD562FEQ92205575-C1368600-FFBC-456A-BB04-9B363F25907EQ92242269-3C50697D-B345-451B-BBE4-485DA5445D0BQ96137252-D858965A-8AF4-4D41-87CB-F9AEBC16E0F0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Syuichi Tetsuka
@ast
Syuichi Tetsuka
@en
Syuichi Tetsuka
@es
Syuichi Tetsuka
@nl
Syuichi Tetsuka
@sl
type
label
Syuichi Tetsuka
@ast
Syuichi Tetsuka
@en
Syuichi Tetsuka
@es
Syuichi Tetsuka
@nl
Syuichi Tetsuka
@sl
prefLabel
Syuichi Tetsuka
@ast
Syuichi Tetsuka
@en
Syuichi Tetsuka
@es
Syuichi Tetsuka
@nl
Syuichi Tetsuka
@sl
P106
P31
P496
0000-0003-2654-368X